| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/21/1999 | EP0909816A1 Anti-fas antibodies |
| 04/21/1999 | EP0909271A1 Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation |
| 04/21/1999 | EP0909181A1 Novel compounds |
| 04/21/1999 | EP0909178A1 Interleukin-8 as an antiviral and antitumor agent |
| 04/21/1999 | EP0909173A1 Topical administration of certain azaspiranes to prevent or treat skin conditions associated with hyperproliferation of skin cells and/or immunologically mediated disorders |
| 04/21/1999 | EP0909171A1 Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1 |
| 04/21/1999 | EP0909169A1 Medical use |
| 04/21/1999 | EP0793641B1 Metalloproteinase inhibitors |
| 04/21/1999 | EP0717731B1 Difluoro statone antiviral analogs |
| 04/21/1999 | EP0369000B1 Macrocyclic complexes of yttrium, the lanthanides and the actinides having peripheral coupling functionalities |
| 04/21/1999 | CN1214734A SCF analog compositions and method |
| 04/21/1999 | CN1214690A Specific immunophilin ligands as antiasthmatics and immunosuppressants |
| 04/21/1999 | CN1214631A Use of rapamycin derivatives in vasculopathies and xenotransplantation |
| 04/21/1999 | CN1214629A Solid instant-release forms of administration and process for producing the same |
| 04/20/1999 | US5895653 Sterile iron(iii) hydroxide; water in oil emulsion; antigens, immunogens; adsorbed interleukin, cytokine and/or interferon |
| 04/20/1999 | CA2138447C Use of 2-methylamino-2-phenylcyclohexanone for the treatment of bacterial, fungal, virus or protozoan infections as well as for immunomodulation |
| 04/15/1999 | WO1999018208A1 101 human secreted proteins |
| 04/15/1999 | WO1999018120A1 Deuterated cyclosporine analogs and their use as immunomodulating agents |
| 04/15/1999 | WO1999018076A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/15/1999 | WO1999018074A1 Novel lactam metalloprotease inhibitors |
| 04/15/1999 | WO1999018070A1 Novel vitamin d analogues |
| 04/15/1999 | WO1999017801A2 Materials and methods relating to the stimulation of cells |
| 04/15/1999 | WO1999017799A1 Cytoplasmic dipeptidylpeptidase iv from human t-cells |
| 04/15/1999 | WO1999017787A2 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 04/15/1999 | WO1999017783A1 Imine-forming polysaccharides, preparation thereof and the use thereof as adjuvants and immunostimulants |
| 04/15/1999 | WO1999017773A1 Compounds and methods |
| 04/15/1999 | WO1999017743A1 Dosage forms having improved release properties |
| 04/15/1999 | WO1999009054A3 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 04/15/1999 | WO1998058945A9 Compounds encoding the protective m-like protein of streptococcus equi and assays therefor |
| 04/15/1999 | WO1998052582A8 Non-myeloablative tolerogenic treatment |
| 04/15/1999 | WO1998048022A9 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 04/15/1999 | WO1998046645A3 Method for the production of antihuman antigen receptors and uses thereof |
| 04/15/1999 | DE19744127A1 Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with Cyclopropylringen in the side chains, processes and intermediates for their preparation and their use for the production of pharmaceuticals |
| 04/15/1999 | CA2306273A1 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 04/15/1999 | CA2305805A1 Compounds and methods |
| 04/15/1999 | CA2305685A1 101 human secreted proteins |
| 04/15/1999 | CA2305679A1 Novel lactam metalloprotease inhibitors |
| 04/15/1999 | CA2305599A1 Imine-forming polysaccharides, preparation thereof and the use thereof as adjuvants and immunostimulants |
| 04/15/1999 | CA2304152A1 Novel vitamin d analogues |
| 04/15/1999 | CA2303449A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/15/1999 | CA2273274A1 Dosage forms having improved release properties |
| 04/14/1999 | EP0908517A2 Viral vaccines |
| 04/14/1999 | EP0908514A1 LicD1 polyperides from Streptococcus pneumoniae |
| 04/14/1999 | EP0908179A1 Treatment of cell-mediated immune diseases |
| 04/14/1999 | EP0908176A1 Intravenous administration form of thalidomide for the therapy of immunologic diseases |
| 04/14/1999 | EP0907737A1 Il-6 mutein |
| 04/14/1999 | EP0907736A2 Cc-type chemokines |
| 04/14/1999 | EP0907732A2 Polynucleotides encoding secreted proteins |
| 04/14/1999 | EP0907730A1 Haemopoietin receptor and genetic sequences encoding same |
| 04/14/1999 | EP0907661A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF alpha v beta 5 MEDIATED ANGIOGENESIS |
| 04/14/1999 | EP0907652A1 Immunosuppressive compounds and methods |
| 04/14/1999 | EP0907378A1 Concentrated antibody preparation |
| 04/14/1999 | EP0907376A1 Novel compounds |
| 04/14/1999 | EP0907375A1 Novel compounds |
| 04/14/1999 | EP0907370A1 Hla-a2.1 binding peptides and their uses |
| 04/14/1999 | EP0907365A1 Novel formulation |
| 04/14/1999 | EP0810991B1 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists |
| 04/14/1999 | EP0759934B1 Neurotensin antagonist peptides |
| 04/14/1999 | EP0669938B1 PEPTIDE DERIVATIVES OF $g(a)-MSH AND THEIR APPLICATION |
| 04/14/1999 | EP0621789B1 Pharmaceutical pentapeptide compositions and methods of use thereof |
| 04/14/1999 | EP0595924B1 Platelet activating factor antagonists |
| 04/14/1999 | EP0548200B1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 04/14/1999 | CN1214083A Mixture of recominant vaccinia vectors as polyenv vaccines for HIV |
| 04/14/1999 | CN1214051A Induction of immune responese against desired determinants |
| 04/14/1999 | CN1214050A Human tumor necrosis factor delta and epsilon |
| 04/14/1999 | CN1214048A Benzopyran derivatives having leukotriene-antagonistic action |
| 04/13/1999 | US5894019 Topically applied pharmaceutical composition, method of preparing it and its use |
| 04/13/1999 | CA2143216C 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics |
| 04/13/1999 | CA2110437C 15-deoxysperqualin analogs, their method of preparation and their use in therapeutics |
| 04/13/1999 | CA2045553C Process for the preparation of vinyl ethers |
| 04/13/1999 | CA1340494C Induction of tolerance to a foreign antigen |
| 04/08/1999 | WO1999016877A1 Amino-terminally truncated rantes as chemokine antagonists |
| 04/08/1999 | WO1999016876A1 Amino-terminally truncated mcp-2 as chemokine antagonists |
| 04/08/1999 | WO1999016770A1 Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic |
| 04/08/1999 | WO1999016745A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 04/08/1999 | WO1999016467A1 Non-anaphylactic forms of allergens and their use |
| 04/08/1999 | WO1999016456A1 Biologically active preparation, complex of such preparations and immuno-stimulation method |
| 04/08/1999 | WO1999016455A1 Mannose receptor bearing cell line and antigen composition |
| 04/08/1999 | WO1999016452A1 THERAPEUTICALLY EFFECTIVE 1α, 25-DIHYDROXYVITAMIN D3 ANALOGS |
| 04/08/1999 | WO1999003882A3 Human leukocyte calcium activated potassium channel polypeptide |
| 04/08/1999 | WO1998057993A9 Secretory immunoglobulin produced by single cells and methods for making and using same |
| 04/08/1999 | WO1998056919A9 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 04/08/1999 | WO1998056913A9 Smad6 and uses thereof |
| 04/08/1999 | WO1998056410A9 Utilization of wolinella succinogenes asparaginase to treat diseases associated with asparagine dependence |
| 04/08/1999 | WO1998055154A9 Radioprotectant for peptides labeled with radioisotope |
| 04/08/1999 | WO1998052549A3 Use of fumaric acid derivatives |
| 04/08/1999 | CA2305140A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 04/08/1999 | CA2305017A1 Amino-terminally truncated mcp-2 as chemokine antagonists |
| 04/08/1999 | CA2304827A1 Amino-terminally truncated rantes as chemokine antagonists |
| 04/08/1999 | CA2304056A1 Therapeutically effective 1.alpha., 25-dihydroxyvitamin d3 analogs |
| 04/08/1999 | CA2245924A1 A method of identifying agonists and antagonists for tumor necrosis related receptors tr1, tr3 and tr5 |
| 04/07/1999 | EP0906909A1 Novel hydroxy and polyhydroxy derivatives of coumarin, peperation thereof and antiviral action thereof |
| 04/07/1999 | EP0906428A1 Use of interleukin-10 to produce a population of suppressor cells |
| 04/07/1999 | EP0906422A1 Human cell death-associated protein |
| 04/07/1999 | EP0906421A1 Enhanced efficacy of liposomal antisense delivery |
| 04/07/1999 | EP0906307A1 Substituted imidazoles having cytokine inhibitory activity |
| 04/07/1999 | EP0906303A1 Ring-fused dihydropyranes, process for the preparation and use thereof |
| 04/07/1999 | EP0906286A1 5-aminopyrazoles useful as selective inhibitors of the protein tyrosine kinase p56ick |
| 04/07/1999 | EP0906279A1 Novel pyrrole derivatives |
| 04/07/1999 | EP0906276A1 Novel vitamin d analogues |